Juan Yu

731 total citations
29 papers, 515 citations indexed

About

Juan Yu is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Juan Yu has authored 29 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 9 papers in Cardiology and Cardiovascular Medicine and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Juan Yu's work include Cardiac Ischemia and Reperfusion (6 papers), Cardiac Fibrosis and Remodeling (5 papers) and Genetic factors in colorectal cancer (3 papers). Juan Yu is often cited by papers focused on Cardiac Ischemia and Reperfusion (6 papers), Cardiac Fibrosis and Remodeling (5 papers) and Genetic factors in colorectal cancer (3 papers). Juan Yu collaborates with scholars based in China and United States. Juan Yu's co-authors include Jianhua Zhan, Yuxiang Ma, Yan Huang, Yunpeng Yang, Wenfeng Fang, Li Zhang, Hongyun Zhao, Sheng Jin, Jianyong Qi and Jiashin Wu and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Juan Yu

27 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juan Yu China 13 215 170 150 99 70 29 515
Qiang Sun China 15 239 1.1× 319 1.9× 74 0.5× 238 2.4× 75 1.1× 41 663
Tomokazu Tanaka Japan 15 120 0.6× 260 1.5× 92 0.6× 185 1.9× 112 1.6× 36 580
Muhammad Tarek Abdel Ghafar Egypt 15 96 0.4× 286 1.7× 81 0.5× 186 1.9× 36 0.5× 52 594
Xiang Qu China 14 167 0.8× 318 1.9× 121 0.8× 329 3.3× 84 1.2× 48 737
Lihua Shang China 13 269 1.3× 266 1.6× 91 0.6× 128 1.3× 59 0.8× 33 640
Silin Lv China 11 69 0.3× 209 1.2× 76 0.5× 54 0.5× 47 0.7× 20 404
Yuanzhou He China 15 55 0.3× 300 1.8× 195 1.3× 164 1.7× 46 0.7× 31 608
Zifan Zeng China 12 59 0.3× 189 1.1× 67 0.4× 66 0.7× 37 0.5× 25 362
Frank J. Vittimberga United States 11 245 1.1× 192 1.1× 156 1.0× 91 0.9× 239 3.4× 12 642

Countries citing papers authored by Juan Yu

Since Specialization
Citations

This map shows the geographic impact of Juan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Yu more than expected).

Fields of papers citing papers by Juan Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Yu. The network helps show where Juan Yu may publish in the future.

Co-authorship network of co-authors of Juan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Yu. A scholar is included among the top collaborators of Juan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Yu. Juan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Lingqiang, Sha Ma, Juan Yu, et al.. (2025). Human umbilical cord mesenchymal stem cell-derived exosomal miR-199a-3p inhibits the MAPK4/NF-κB signaling pathway to relieve osteoarthritis. World Journal of Stem Cells. 17(4). 103919–103919. 6 indexed citations
2.
He, Fang, Juan Yu, Sha Ma, et al.. (2024). γδT Cells Induce the Inflammatory Response of Human Fibroblast-Like Synoviocytes Directly or by Stimulating B Cells to Activate IL-17/STAT3 Signaling Pathway. International Archives of Allergy and Immunology. 185(12). 1154–1165. 1 indexed citations
3.
He, Fang, Juan Yu, Sha Ma, et al.. (2024). MiR-34a promotes mitochondrial pathway of apoptosis in human salivary gland epithelial cells by activating NF-κB signaling. Archives of Biochemistry and Biophysics. 758. 110063–110063. 2 indexed citations
4.
Wang, Xu, et al.. (2023). Clinicopathological characteristics of autoimmune gastritis: A single-center retrospective study. Clinics and Research in Hepatology and Gastroenterology. 47(7). 102154–102154. 1 indexed citations
6.
Huang, Wei-Feng, et al.. (2022). An Unusual Case of Gastrointestinal Polyposis. Gastroenterology. 163(3). e1–e3.
7.
Chen, Yiping, Juan Yu, & Wei-Feng Huang. (2022). An Unusual Cause of Abdominal Pain: IgA Vasculitis. Clinical Gastroenterology and Hepatology. 20(7). A17–A18.
8.
Wang, Jing, Sha Ma, Juan Yu, et al.. (2021). MiR-9-5p promotes M1 cell polarization in osteoarthritis progression by regulating NF-κB and AMPK signaling pathways by targeting SIRT1. International Immunopharmacology. 101(Pt A). 108207–108207. 15 indexed citations
9.
Qi, Jianyong, et al.. (2020). Songling Xuemaikang Capsule inhibits isoproterenol-induced cardiac hypertrophy via CaMKIIδ and ERK1/2 pathways. Journal of Ethnopharmacology. 253. 112660–112660. 15 indexed citations
10.
Zhang, Jiangong, Huifang Xu, Liyang Zheng, et al.. (2020). Determinants of Participation and Detection Rate of Colorectal Cancer From a Population-Based Screening Program in China. Frontiers in Oncology. 10. 1173–1173. 23 indexed citations
11.
Yu, Juan, et al.. (2020). Protective Mechanisms of Suxiao Jiuxin Pills (速效救心丸) on Myocardial Ischemia-Reperfusion Injury in vivo and in vitro. Chinese Journal of Integrative Medicine. 26(8). 583–590. 5 indexed citations
12.
Yu, Juan, Wei Yang, Wei Wang, et al.. (2019). Involvement of miR-665 in protection effect of dexmedetomidine against Oxidative Stress Injury in myocardial cells via CB2 and CK1. Biomedicine & Pharmacotherapy. 115. 108894–108894. 26 indexed citations
13.
Yang, Yang, et al.. (2018). Pien Tze Huang ameliorates liver injury by inhibiting the PERK/eIF2α signaling pathway in alcohol and high-fat diet rats. Acta Histochemica. 120(6). 578–585. 17 indexed citations
14.
Wang, Pingli, Chengyan Zhang, Juan Yu, et al.. (2017). Clinical profiles and trend analysis of newly diagnosed lung cancer in a tertiary care hospital of East China during 2011–2015. Journal of Thoracic Disease. 9(7). 1973–1979. 10 indexed citations
15.
Yu, Juan, et al.. (2016). Salvianolic Acid B Alleviates Heart Failure by Inactivating ERK1/2/GATA4 Signaling Pathway after Pressure Overload in Mice. PLoS ONE. 11(11). e0166560–e0166560. 26 indexed citations
16.
Qi, Jianyong, Juan Yu, Donghui Huang, et al.. (2016). Salvianolate reduces murine myocardial ischemia and reperfusion injury via ERK1/2 signaling pathways in vivo. Chinese Journal of Integrative Medicine. 23(1). 40–47. 21 indexed citations
17.
Jin, Sheng, Wenfeng Fang, Juan Yu, et al.. (2016). Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer. Scientific Reports. 6(1). 20090–20090. 144 indexed citations
18.
Qi, Jianyong, Qin Liu, Kaizheng Gong, et al.. (2014). Apocynum Tablet Protects against Cardiac Hypertrophy via Inhibiting AKT and ERK1/2 Phosphorylation after Pressure Overload. Evidence-based Complementary and Alternative Medicine. 2014(1). 769515–769515. 6 indexed citations
19.
Qi, Jianyong, Juan Yu, Lei Wang, et al.. (2013). Tongguan Capsule Protects against Myocardial Ischemia and Reperfusion Injury in Mice. Evidence-based Complementary and Alternative Medicine. 2013. 1–8. 11 indexed citations
20.
Yu, Juan, Jingjing Huang, Yan Liang, et al.. (2011). Lack of association between apolipoprotein C3 gene polymorphisms and risk of coronary heart disease in a Han population in East China. Lipids in Health and Disease. 10(1). 200–200. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026